Yoel, U., Alkobi Weiss, H., Goldbart, A., Silverman Siris, E., Fisher, D. L., Hassan, L., & Fraenkel, M. (2024). The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates—a single-center retrospective study. Osteoporosis International. https://doi.org/10.1007/s00198-024-07325-9

McClung, M. R., Betah, D., Deignan, C., Shi, Y., Timoshanko, J., & Cosman, F. (2023). Romosozumab Efficacy in Postmenopausal Women With No Prior Fracture Who Fulfill Criteria for Very High Fracture Risk. Endocrine Practice, 29(9), 716–722. https://doi.org/10.1016/j.eprac.2023.06.011

Womack, J. A., Murphy, T. E., Leo-Summers, L., Kidwai-Khan, F., Skanderson, M., Gill, T. M., Gulanski, B., Rodriguez-Barradas, M. C., Tien, P. C., Yin, M. T., & Hsieh, E. (2023). Performance of a modified fracture risk assessment tool for fragility fracture prediction among older veterans living with HIV. AIDS, 37(9), 1399–1407. https://doi.org/10.1097/qad.0000000000003566

Lewiecki, E. M., Bilezikian, J. P., Binkley, N., Bouxsein, M. L., Bukata, S. V., Dempster, D. W., Drake, M. T., McClung, M. R., Miller, P. D., Rosenthal, E., & Tosi, L. L. (2022). Proceedings of the 2022 Santa Fe Bone Symposium: Current Concepts in the Care of Patients with Osteoporosis and Metabolic Bone Diseases. Journal of Clinical Densitometry, 25(4), 649–667. https://doi.org/10.1016/j.jocd.2022.10.002

Bandeira, L., Silva, B. C., & Bilezikian, J. P. (2022). Male osteoporosis. Archives of Endocrinology and Metabolism, 66(5), 739–747. https://doi.org/10.20945/2359-3997000000563

Cosman, F., Huang, S., McDermott, M., & Cummings, S. R. (2020). Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses. Journal of Bone and Mineral Research, 37(11), 2112–2120. https://doi.org/10.1002/jbmr.4705

LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022). The clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis International, 33(10), 2049–2102. https://doi.org/10.1007/s00198-021-05900-y

Schwartz, A. V., Backlund, J.-Y. C., de Boer, I. H., Rubin, M. R., Barnie, A., Farrell, K., Trapani, V. R., Gregory, N. S., Wallia, A., Bebu, I., Lachin, J. M., Braffett, B. H., & Gubitosi-Klug, R. (2022). Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study. The Lancet Diabetes & Endocrinology, 10(7), 509–518. https://doi.org/10.1016/s2213-8587(22)00103-6

Cosman, F., Cooper, C., Wang, Y., Mitlak, B., Varughese, S., & Williams, S. A. (2022). Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study. Osteoporosis International, 33(8), 1703–1714. https://doi.org/10.1007/s00198-022-06413-y